New York, NY -- (SBWIRE) -- 12/09/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Amarin Corporation plc (ADR) (NASDAQ:AMRN), Dendreon Corporation (NASDAQ:DNDN), Globalstar, Inc (OTCMKTS:GSAT), American International Group Inc (NYSE:AIG)
Amarin Corporation plc (ADR) (NASDAQ:AMRN) showed a volume of 4.44 million shares by the end of last trade whereas the average volume of the stock remained 6.30million shares. The stock opened the session at $1.81 but then moved to $1.77. At that price, the stock showed a negative performance of -2.21%. Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company’s product candidate is AMR101, an ultra-pure omega-3 fatty acid. It is developing AMR101 for the treatment of patients with high triglyceride levels, or hypertriglyceridemia. In September 2011, it filed a New Drug Application (NDA), with the United States Food and Drug Administration (FDA).
Will AMRN Get Buyers Even After The Recent Rally? Find Out Here
Dendreon Corporation (NASDAQ:DNDN) opened the session at $3.04 and closed the session at $3.01. The stock showed a negative performance of -0.33% in previous trading session. Traded with volume of 2.21 million shares in the prior session and the average volume of the stock remained 4.30 million shares. Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may significantly improve cancer treatment options for patients. The Company's product portfolio includes active cellular immunotherapies and a small molecule product candidate that could be applicable to treating multiple types of cancers. PROVENGE (sipuleucel-T), is the Company's first commercialized product approved by the United States Food and Drug Administration (FDA),
Has DNDN Found The Bottom And Ready To Gain Momentum? Find Out Here
Globalstar, Inc (OTCMKTS:GSAT) opened the session at $1.74 and closed the session at $1.74. The stock showed a positive performance of 1.16% in previous trading session. Traded with volume of 726,117.00 shares in the prior session and the average volume of the stock remained 3.55 million shares. The beta of the stock remained 3.08. Globalstar, Inc. (Globalstar) is a provider of mobile voice and data communications services globally via satellite. Globalstar’s satellite communications business, by providing critical mobile communications to the Company's subscribers, serves principally recreation and personal; government; public safety and disaster relief; oil and gas; maritime and fishing; natural resources, mining and forestry; construction; utilities and transportation.
Why Should Investors Buy GSAT After The Recent Gain? Just Go Here and Find Out
American International Group Inc (NYSE:AIG) the stock advanced 2.82% and finished the session at $49.55. Traded with volume of 9.83 million shares in the prior session and the average volume of the stock remained 11.51 million shares. The beta of the stock remained 3.34. American International Group, Inc. (AIG) is a global insurance company. The Company provides a range of property casualty insurance, life insurance, retirement products, mortgage insurance and other financial services to customers in more than 130 countries. It diverse offerings include products and services that help businesses and individuals protect their assets, manage risks and provide for retirement security.
Will AIG Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)